May Measurement Month 2018: an analysis of blood pressure screening campaign results from Poland.

Blood pressure Control Disease awareness Hypertension Screening Treatment

Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 5 9 2020
Statut: ppublish

Résumé

Hypertension remains the most important cardiovascular risk factor in Poland. May Measurement Month is a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for blood pressure (BP) screening and demonstrating the potential of the opportunistic BP measurements. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in 146 sites in May 2018. Blood pressure was measured in 6450 subjects (mean age: 41 ± 15 years; 59% females). After multiple imputation, the age and sex standardized systolic and diastolic BP was 126.7/78.4 mmHg in the whole analysed group, 132.8/81.3 mmHg in subjects taking antihypertensive drugs, and 125.7/78.0 mmHg in those not taking any antihypertensive drugs. After multiple imputation, the proportions of subjects with high BP (systolic ≥140 mmHg or diastolic ≥90 mmHg or on treatment for raised BP) were 22.2% in the whole analysed group, 39.2% in subjects taking antihypertensive drugs, and 18.6% those not taking any antihypertensive drugs. Overall, hypertension was present in 32.8% of participants, among them 38.7% were not aware of the disease, 53.1% were taking antihypertensive drugs, and 32.3% had BP controlled to target (<140/90 mmHg). Blood pressure was increasing with increasing body mass index and alcohol intake. Smokers and project participants with diabetes had increased average BP. In conclusion, this project provides additional evidence for a considerable potential for further reduction of cardiovascular risk through improvement in detection and treatment of hypertension in Poland.

Identifiants

pubmed: 32884486
doi: 10.1093/eurheartj/suaa041
pii: suaa041
pmc: PMC7455275
doi:

Types de publication

Journal Article

Langues

eng

Pagination

H108-H111

Informations de copyright

Published on behalf of the European Society of Cardiology. © The Author(s) 2020.

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Lancet. 2017 Apr 29;389(10080):1678-1680
pubmed: 28463128
Eur Heart J Suppl. 2019 Apr;21(Suppl D):D97-D100
pubmed: 31043891
Arch Med Sci. 2018 Aug;14(5):951-961
pubmed: 30154875
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
Arch Med Sci. 2018 Aug;14(5):979-987
pubmed: 30154878

Auteurs

Piotr Jankowski (P)

I Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, Kraków 31-501, Poland.

Maciej Banach (M)

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Żeromskiego 113, Łódz 90-549, Poland.

Jolanta Małyszko (J)

Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, Banacha 1a, Warszawa 02-097, Poland.

Mirosław Mastej (M)

Mastej Medical Center, Staszica 21, Jasło 38-200, Poland.

Andrzej Tykarski (A)

Department of Hypertension, Angiology and Internal Medicine, Poznan University of Medical Sciences, Długa1/2, Poznan 61-848, Poland.

Krzysztof Narkiewicz (K)

Department of Hypertension and Diabetology, Medical University of Gdańsk, Dębinki 7, Gdansk 80-952, Poland.

Piotr Hoffman (P)

Department of Congenital Heart Disease, Institute of Cardiology, Alpejska 42, Warszawa 04-628, Poland.

Michał P Nowicki (MP)

Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Pomorska 251, Łódz 92-213, Poland.

Tomasz Tomasik (T)

Department of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bocheńska 4, Kraków 31-061, Poland.

Adam Windak (A)

Department of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bocheńska 4, Kraków 31-061, Poland.

Agnieszka Olszanecka (A)

I Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, Kraków 31-501, Poland.

Maciej Tomaszewskil (M)

Division of Cardiovascular Sciences, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.

Agnieszka Motyl (A)

Medicover Poland, Jerozolimskie 96, Warszawa 00-807, Poland.

Dariusz Nowak (D)

Municipal Hospital, Mickiewicza 12, Częstochowa 42-200, Poland.

Łukasz Skowron (Ł)

Department of Gastroenterology, Endocrinology and Internal Diseases, Military Institute of Medicine, Szaserów 128, Warszawa 04-141, Poland.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK.

Anca Chis Ster (AC)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Xia Xin (X)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Jacek Jóźwiak (J)

Department of Family Medicine and Public Health, Faculty of Medicine, University of Opole, Oleska 48, Opole 45-052, Poland.

Classifications MeSH